Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Author: Al-SadawiMohammed, BattishaAyman, DoughemKarim, KonduruLakshmi, MadoukhBader, ShaikhShakil, SheikhOmar

Paper Details 
Original Abstract of the Article :
Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs. It is generally well-tolerated and has a safe profile in pregnancy. However, hydralazine can induce immune-med...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226194/

データ提供:米国国立医学図書館(NLM)

Hydralazine and Vasculitis: Navigating the Shifting Sands of Side Effects

Hydralazine, a medication commonly used to manage high blood pressure, can sometimes have unexpected side effects. This research delves into a rare but potentially life-threatening side effect called hydralazine-induced ANCA associated vasculitis (AAV). The researchers describe a case of a patient who developed severe lung and kidney complications as a result of this side effect. They emphasize the importance of prompt diagnosis and early management to prevent serious consequences.

A Sandstorm in the Desert: Recognizing the Danger

This case study serves as a cautionary reminder of the potential risks associated with hydralazine, highlighting the importance of close monitoring and early intervention in patients experiencing unexpected symptoms.

Staying Safe in the Desert: Managing Vasculitis

This research underscores the importance of being aware of the potential side effects of medications, especially those that can affect the kidneys and lungs. It emphasizes the need for vigilant monitoring and prompt treatment to prevent serious complications.

Dr.Camel's Conclusion

This case study reminds us that even medications with a generally good safety profile can have unexpected consequences. Navigating the desert of side effects requires constant vigilance and a commitment to patient safety.

Date :
  1. Date Completed 2021-06-22
  2. Date Revised 2022-03-02
Further Info :

Pubmed ID

32418528

DOI: Digital Object Identifier

PMC8226194

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.